Literature DB >> 25356179

Regenerating gene family member 4 promotes growth and migration of gastric cancer through protein kinase B pathway.

Jiamiao Huang1, Ya Yang1, Jian Yang1, Xian Li1.   

Abstract

Regenerating gene family member 4 (REG4), a secreted protein, is overexpressed in several cancers, including gastric cancer. The present study was undertaken to determine the roles of REG4 in the growth of gastric cancer in the nude mice and in the proliferation and migration in human gastric cancer cell line and its downstream signaling pathway. Gastric cancer models were elicited by intraperitoneally injecting MKN45 human gastric cancer cells and the tumor size was measured every other day. The expressions of REG4 mRNA and protein were increased in the gastric cancer tissues from gastric cancer patients. REG4 increased the gastric tumor weight and size in the nude mice, and promoted the proliferation and migration of gastric cancer cells MKN45. Adeno-associated viral (AAV)-mediated knockdown of REG4 decreased the gastric tumor weight and size in the nude mice, and suppressed the proliferation and migration of MKN45 cells. REG4 increased the expression of phosphorylated protein kinase B (Akt). Triciribine hydrate (TCN), the inhibitor of Akt, decreased the gastric tumor weight and size in the nude mice and abolished REG4-induced weight and size increase of the tumor. TCN also inhibited proliferation and migration and abolished REG4-induced proliferation and migration increase of human gastric cell line MKN45. These results indicate that REG4 promotes the growth, proliferation and migration of gastric cancer through Akt pathway.

Entities:  

Keywords:  Regenerating gene family member 4; gastric cancer; migration; proliferation; protein kinase B

Year:  2014        PMID: 25356179      PMCID: PMC4211829     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  26 in total

Review 1.  The hallmarks of cancer.

Authors:  D Hanahan; R A Weinberg
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

2.  Serum REG4 level is a predictive biomarker for the response to preoperative chemoradiotherapy in patients with pancreatic cancer.

Authors:  Hidetoshi Eguchi; Osamu Ishikawa; Hiroaki Ohigashi; Hidenori Takahashi; Masahiko Yano; Kinji Nishiyama; Yasuhiko Tomita; Rie Uehara; Akio Takehara; Yusuke Nakamura; Hidewaki Nakagawa
Journal:  Pancreas       Date:  2009-10       Impact factor: 3.327

3.  Serum tumor antigen REG4 as a useful diagnostic biomarker in gastric cancer.

Authors:  Yuji Kobayashi; Yasumasa Niwa; Masahiro Tajika; Hiroki Kawai; Shinya Kondo; Kazuo Hara; Nobumasa Mizuno; Susumu Hijioka; Akira Sawaki; Keitaro Matsuo; Hidewaki Nakagawa; Yusuke Nakamura; Kenji Yamao
Journal:  Hepatogastroenterology       Date:  2010 Nov-Dec

Review 4.  Significance of regenerating islet-derived type IV gene expression in gastroenterological cancers.

Authors:  Masakatsu Numata; Takashi Oshima
Journal:  World J Gastroenterol       Date:  2012-07-21       Impact factor: 5.742

5.  Reg4 protects against acinar cell necrosis in experimental pancreatitis.

Authors:  Guoyong Hu; Jiaqing Shen; Li Cheng; Chuanyong Guo; Xuanfu Xu; Feng Wang; Li Huang; Lijuan Yang; Miao He; Di Xiang; Shunying Zhu; Mingyuan Wu; Yan Yu; Wei Han; Xingpeng Wang
Journal:  Gut       Date:  2010-12-30       Impact factor: 23.059

6.  Association of smoking history with cancer recurrence and survival in stage III-IV male gastric cancer patients.

Authors:  Mi Ah Han; Young-Woo Kim; Il Ju Choi; Myueng Guen Oh; Chan Gyoo Kim; Jong Yeul Lee; Soo-Jeong Cho; Bang Wool Eom; Hong Man Yoon; Keun Won Ryu
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-07-31       Impact factor: 4.254

7.  Reg IV activates the epidermal growth factor receptor/Akt/AP-1 signaling pathway in colon adenocarcinomas.

Authors:  Kumar S Bishnupuri; Qizhi Luo; Nabendu Murmu; Courtney W Houchen; Shrikant Anant; Brian K Dieckgraefe
Journal:  Gastroenterology       Date:  2006-01       Impact factor: 22.682

8.  [Analysis of Reg IV expression in peritoneal dissemination of gastric cancer using real-time RT-PCR].

Authors:  Kouji Miyagawa; Chohei Sakakura; Susumu Nakashima; Tetsuji Yoshikawa; Shuichi Kin; Yuen Nakase; Kenichirou Fukuda; Akeo Hagiwara; Yasushi Okazaki; Yoshihide Hayashizaki; Hisakazu Yamagishi
Journal:  Gan To Kagaku Ryoho       Date:  2005-10

9.  Reg IV enhances peritoneal metastasis in gastric carcinomas.

Authors:  H Kuniyasu; N Oue; T Sasahira; L Yi; Y Moriwaka; T Shimomoto; K Fujii; H Ohmori; W Yasui
Journal:  Cell Prolif       Date:  2009-02       Impact factor: 6.831

10.  REG Ialpha protein mediates an anti-apoptotic effect of STAT3 signaling in gastric cancer cells.

Authors:  Akira Sekikawa; Hirokazu Fukui; Shigehiko Fujii; Kazuhito Ichikawa; Shigeki Tomita; Johji Imura; Tsutomu Chiba; Takahiro Fujimori
Journal:  Carcinogenesis       Date:  2007-11-16       Impact factor: 4.944

View more
  8 in total

1.  Exosomal circ_0001190 Regulates the Progression of Gastric Cancer via miR-586/SOSTDC1 Axis.

Authors:  Chao Liu; Jing Yang; Fengchi Zhu; Zhiying Zhao; Lixue Gao
Journal:  Biochem Genet       Date:  2022-02-09       Impact factor: 1.890

2.  Combined targeting of vascular endothelial growth factor C (VEGFC) and P65 using miR-27b-3p agomir and lipoteichoic acid in the treatment of gastric cancer.

Authors:  Yejia Cui; Shaolong Huang; Jin Cao; Jinjun Ye; Haohai Huang; Dan Liao; Yufeng Yang; Wanchan Chen; Rong Pu
Journal:  J Gastrointest Oncol       Date:  2021-02

Review 3.  Treatment Strategies of Gastric Cancer-Molecular Targets for Anti-angiogenic Therapy: a State-of-the-art Review.

Authors:  Magdalena Tyczyńska; Paweł Kędzierawski; Kaja Karakuła; Jacek Januszewski; Krzysztof Kozak; Monika Sitarz; Alicja Forma
Journal:  J Gastrointest Cancer       Date:  2021-03-24

4.  MicroRNA-27b, microRNA-101 and microRNA-128 inhibit angiogenesis by down-regulating vascular endothelial growth factor C expression in gastric cancers.

Authors:  Hai-Ting Liu; Ai-Yan Xing; Xu Chen; Ran-Ran Ma; Ya-Wen Wang; Duan-Bo Shi; Hui Zhang; Peng Li; Hong-Fang Chen; Yu-Hong Li; Peng Gao
Journal:  Oncotarget       Date:  2015-11-10

Review 5.  The Clinical Significance and Mechanisms of REG4 in Human Cancers.

Authors:  Junyan Zhang; Zhi Zhu; Zhifeng Miao; Xuanzhang Huang; Zhe Sun; Huimian Xu; Zhenning Wang
Journal:  Front Oncol       Date:  2021-01-08       Impact factor: 6.244

6.  CDX2 and Reg IV expression and correlation in gastric cancer.

Authors:  Dandan Chai; Huifen Du; Kesheng Li; Xueliang Zhang; Xiaoqin Li; Xiaoning Zhao; Xiaowen Lian; Yang Xu
Journal:  BMC Gastroenterol       Date:  2021-02-27       Impact factor: 3.067

Review 7.  REG4 promotes the proliferation and anti-apoptosis of cancer.

Authors:  Hua-Chuan Zheng; Hang Xue; Cong-Yu Zhang
Journal:  Front Cell Dev Biol       Date:  2022-09-12

8.  Expression of Reg IV and SOX9 and their correlation in human gastric cancer.

Authors:  Na Zhang; Dandan Chai; Huifen Du; Kesheng Li; Wenguang Xie; Xingwen Li; Rong Yang; Xiaowen Lian; Yang Xu
Journal:  BMC Cancer       Date:  2018-03-27       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.